Elafibranor(CAS: 923978-27-2)

Elafibranor (CAS: 923978-27-2) is a crystalline white to off-white powder. It has a molecular weight of approximately 481.38 g/mol. Elafibranor is slightly soluble in water and has low solubility in organic solvents. It is relatively stable under normal conditions but may react with strong acids or bases. Elafibranor is of interest due to its pharmacological activities.

Elafibranor (CAS: 923978-27-2) is typically synthesized via multi-step organic synthesis involving protection and deprotection of functional groups. The synthesis often employs palladium catalysts for cross-coupling reactions, ensuring high selectivity and yield. The final step involves purification by crystallization from a suitable solvent.

Elafibranor (CAS: 923978-27-2) is primarily used in the pharmaceutical industry for its potential therapeutic benefits. It has been studied for its effects on metabolic disorders and has shown promise in treating non-alcoholic steatohepatitis (NASH). It is also of interest in research for its potential applications in diabetes and other metabolic diseases.

When handling Elafibranor (CAS: 923978-27-2), it is important to use personal protective equipment (PPE) such as gloves, lab coat, and safety glasses. Work should be conducted in a well-ventilated area or fume hood. Spills should be cleaned up immediately using appropriate materials, and the Material Safety Data Sheet (MSDS) should be consulted for specific spill procedures. Proper storage in a cool, dry place away from strong acids and bases is recommended.